← Feed

Zimmermann Martine

SEC Form 4 insider
Candel Therapeutics, Inc. ($CADL), LIGAND PHARMACEUTICALS INC ($LGND)
1 thesis · first seen Sep 10, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$LGNDSEC Form 4bearish
Zimmermann Martine · LIGAND PHARMACEUTICALS INC · 16d agono track record yet
Sold 1,200 @ $285.00 avg · $342,000 · 2026-09-10

Form 4: Zimmermann Martine sold LGND

Zimmermann Martine (Director at LIGAND PHARMACEUTICALS INC) reported an open-market sale of 1,200 shares of LGND at an average $285.00, roughly $342,000, in a Form 4 filed 2026-09-14.

At post $280.65Now $283.49+1.0% since postedas of Sep 18, 4:30 PM ET
1d-1.3%
3d+1.4%
1w—
1m—
3m—
6m—
1y—
View filing on SEC.gov →

End of results.